S-adenosylhomocysteine is associated with subclinical atherosclerosis and renal function in a cardiovascular low-risk population
Adam M. Zawada(Fresenius Medical Care (Germany)), Gunnar H. Heine(Agaplesion Markus Hospital), Judith T. Berg(Saarland University), Kyrill S. Rogacev(Saarland University), Jürgen Geisel(Saarland University), Annika Friedrich(Saarland University), Björn Hummel(Saarland University), Rima Obeid(Saarland University), Heinz Jürgen Roth(Center for HIV and Hepatogastroenterology), Danilo Fliser(Saarland University)
Cited by 44
Related Papers
Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
|JAMA|2014|982
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537
Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia
|FEBS Letters|2006|488
The systemic nature of CKD
|Nature Reviews Nephrology|2017|438
Homocysteine and Dementia: An International Consensus Statement
|Journal of Alzheimer s Disease|2018|360